-- The world’s newest, most advanced family of sound processors for cochlear implant recipients is now approved in Europe --
VALENCIA, Calif.--(BUSINESS WIRE)--Advanced Bionics (AB), a global leader in cochlear implant technology and a company of the Sonova Group, announced today that the Naída CI Q30 and Q90 sound processors* have received TÜV approval, following FDA and Health Canada approval earlier this year. The Naída CI Q Series delivers advanced technology in automation, noise reduction, phone use, and waterproof protection. AB’s newest version of fitting software, SoundWave™ 2.3, also received approval.
VALENCIA, Calif.--(BUSINESS WIRE)--Advanced Bionics (AB), a global leader in cochlear implant technology and a company of the Sonova Group, announced today that the Naída CI Q30 and Q90 sound processors* have received TÜV approval, following FDA and Health Canada approval earlier this year. The Naída CI Q Series delivers advanced technology in automation, noise reduction, phone use, and waterproof protection. AB’s newest version of fitting software, SoundWave™ 2.3, also received approval.
